Tech Center 1600 • Art Units: 1655
This examiner grants 46% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18360766 | LIQUID DISPENSING SYSTEM, COMPONENTS AND FEATURES THEREOF, AND METHODS OF USE THEREOF | Non-Final OA | The Procter & Gamble Company |
| 18441653 | COMPOSITION FOR PREVENTING OR TREATING LIVER FIBROSIS INCLUDING SANGUISORBA OFFICINALIS EXTRACT AS ACTIVE INGREDIENT | Non-Final OA | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY |
| 18262406 | SPIDER MITE REPELLENT | Non-Final OA | RIKEN |
| 18550728 | USE OF A RED ALGA EXTRACT AS NEMATOSTATIC AND/OR NEMATICIDAL AGENT | Non-Final OA | AGRO INNOVATION INTERNATIONAL |
| 18551393 | METHODS OF USING COMPOSITIONS COMPRISING AN ICELAND MOSS EXTRACT | Non-Final OA | Kenvue Brands LLC |
| 17828627 | METHOD FOR IMPROVING DIGESTIVE HEALTH | Final Rejection | Sanford Burnham Prebys Medical Discovery Institute |
| 18608731 | EXTRACTS ENRICHED WITH POLYPHENOLIC COMPOUNDS AND RELATED METHODS | Final Rejection | ATLAS365 INCORPORATED |
| 18548003 | USE OF CANNABIDIOL AND CLOBAZAM IN THE TREATMENT OF CHILDHOOD-ONSET EPILEPSY SYNDROMES | Non-Final OA | Jazz Pharmaceuticals Research UK Limited |
| 18409518 | COMPOSITIONS AND METHODS FOR IMMUNE HEALTH | Non-Final OA | KARALLIEF INC |
| 18532215 | COMPOSITIONS | Non-Final OA | Provexis Natural Products Limited |
| 18286095 | Aristotelia chilensis EXTRACTS FOR TREATING FUNGAL INFECTIONS | Non-Final OA | Institut Za Molekularnu Genetiku I Geneticko Inzenjerstvo Univerziteta E Beolgrade |
| 18281782 | PROCESS FOR PREPARING ABSOLUTES | Non-Final OA | INTERNATIONAL FLAVORS & FRAGRANCES INC. |
| 18374301 | FOOD SUPPLEMENT | Non-Final OA | MICROPHYT |
| 18282890 | THERAPEUTIC LENSES FOR USE AS OCULAR BANDAGE AND SIMULTANEOUSLY FOR THE ADMINISTRATION OF EYE DROPS | Non-Final OA | EYE PHARMA SPA |
| 18466003 | METHOD FOR TREATING AND/OR PREVENTING EDEMATOUS FIBROSCLEROTIC PANNICULOPATHY | Non-Final OA | CALIWAY BIOPHARMACEUTICALS CO., LTD. |
| 18244548 | BIOACTIVE CONCENTRATES AND USES THEREOF | Non-Final OA | Purple Mondo, Inc. |
| 18549434 | SCAFFOLD FOR TISSUE REGENERATION, PARTICULARLY FOR BONE REGENERATION, AND MANUFACTURING METHOD THEREOF | Non-Final OA | PHARMAEXCEED S.R.L. |
| 18270687 | COMPOSITION FOR PREVENTING OR TREATING MACULAR DEGENERATION CONTAINING GINSENG BERRY EXTRACT | Final Rejection | HOLISTIC BIO CO., LTD. |
| 18363793 | COMPOSITIONS AND METHODS COMPRISING HEMP EXTRACT FOR THE TREATMENT OF ANIMALS IN NEED | Non-Final OA | Portland Technology Holdings LLC |
| 17045945 | HEMP EXTRACT FOR TREATMENT OF PAIN IN ANIMALS | Final Rejection | Portland Technology Holdings LLC |
| 18262653 | COMPOSITION COMPRISING COFFEE, COFFEE EXTRACT, AND BYPRODUCT AS ACTIVE INGREDIENT FOR PREVENTION OF CANCER METASTASIS OR FOR ALLEVIATION OR TREATMENT OF CANCER | Final Rejection | DAEJEON UNIVERSITY INDUSTRY-UNIVERSITY COOPERATION FOUNDATION |
| 18262344 | TOPICAL HUMAN MILK FORMULATIONS | Non-Final OA | PROLACTA BIOSCIENCE, INC. |
| 18260956 | MODIFIED RELEASE FORMULATION COMPRISING WITHANOLIDES | Final Rejection | NUTRIVENTIA PRIVATE LIMITED |
| 18219723 | FEED ADDITIVE, LAYING HEN FEED, AND METHOD FOR PRODUCING ASTAXANTHIN EGGS | Non-Final OA | Algae Origin Inc. |
| 18207448 | ACTIVE PHARMACEUTICAL INGREDIENT | Non-Final OA | DAMIT HOLDINGS (PTY) LTD |
| 18039690 | SPECIFIC PATHOGEN FREE FEED COMPOSITION | Final Rejection | Chemovator GmbH |
| 17928952 | COMPOSITION CONTAINING CANNABINOIDS | Non-Final OA | HEALTHCANN SPÓLKA AKCYJNA |
| 17919373 | MEDICAL DEVICE COMPRISING AN ACELLULAR BIOLOGICAL MATRIX AND AT LEAST ONE POLYMER | Final Rejection | PH TECH |
| 17917545 | JELLYFISH COLLAGEN USE | Final Rejection | JELLAGEN LIMITED |
| 17911920 | COMPOSITION FOR ENHANCING UROLITHIN PRODUCTION IN A HUMAN SUBJECT | Final Rejection | Migalis ApS |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy